Left Atrial Blood Stasis and Von Willebrand Factor-ADAMTS13 Homeostasis in Atrial Fibrillation

被引:48
作者
Ammash, Naser [1 ,2 ]
Konik, Ewa A. [1 ,2 ]
McBane, Robert D. [1 ,2 ]
Chen, Dong [2 ,3 ]
Tange, Julie I. [2 ,3 ]
Grill, Diane E. [2 ,4 ]
Herges, Regina M. [2 ,4 ]
McLeod, Thomas G. [2 ]
Friedman, Paul A. [1 ,2 ]
Wysokinski, Waldemar E. [1 ,2 ]
机构
[1] Mayo Clin & Fdn Educ & Res, Div Cardiovasc Med, Rochester, MN 55905 USA
[2] Mayo Clin & Fdn Educ & Res, Dept Internal Med, Rochester, MN 55905 USA
[3] Mayo Clin & Fdn Educ & Res, Dept Lab Med & Pathol, Rochester, MN 55905 USA
[4] Mayo Clin & Fdn Educ & Res, Div Biomed Stat & Informat, Rochester, MN 55905 USA
关键词
stroke; thrombosis; von Willebrand factor; atrial fibrillation; SOLUBLE P-SELECTIN; FLOW VELOCITY; STROKE PREVENTION; THROMBOEMBOLIC RISK; PLATELET ACTIVATION; ENDOTHELIAL DAMAGE; APPENDAGE; ADAMTS13; INDEXES; THROMBOGENESIS;
D O I
10.1161/ATVBAHA.111.232991
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-Left atrial blood stasis is associated with increased risk for left atrial appendage thrombus (LAAT) and stroke in atrial fibrillation (AF). Von Willebrand factor (VWF) is associated with thromboembolism in AF. VWF thrombogenic activity is proportional to multimer size, which is regulated by VWF-cleaving protease (ADAMTS13). Methods and Results-To assess the association between left atrial blood stasis and VWF-ADAMTS13 system, plasma VWF antigen (VWF:Ag), VWF activity (VWF: Act), and ADAMTS13 activity were measured in 414 consecutive patients with nonvalvular AF (age 63 +/- 13 years; 25% women) and in 100 patients (age 64 +/- 14 years; 39% women) with normal sinus rhythm. Spontaneous echocardiographic contrast (SEC), left atrial appendage emptying velocity, and LAAT were assessed by transesophageal echocardiography. Presence and intensity of SEC varied directly with VWF: Ag and VWF: Act but not with ADAMTS13 activity. AF patients with LAAT had higher VWF: Ag (200 +/- 61 versus 155 +/- 52, P=0.0006) and VWF: Act (179 +/- 57 versus 141 +/- 51 P=0.0026) compared with those without LAAT. VWF: Ag and VWF: Act were independent predictors of LAAT after adjustment for CHADS2 score (P=0.0179 and P=0.0497, respectively). Conclusion-The association between VWF and SEC may explain the thrombotic propensity in AF. Elevated VWF: Ag may help identify AF patients at risk for LAAT. (Arterioscler Thromb Vasc Biol. 2011;31:2760-2766.)
引用
收藏
页码:2760 / 2766
页数:7
相关论文
共 38 条
[31]  
Ruggeri Z.M., 1998, WILLEBRAND FACTOR ME, P79
[32]   A new automated screening assay for the diagnosis of von Willebrand disease [J].
Salem, Raneem O. ;
Van Cott, Elizabeth M. .
AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2007, 127 (05) :730-735
[33]   Shear-dependent changes in the three-dimensional structure of human von Willebrand factor [J].
Siedlecki, CA ;
Lestini, BJ ;
KottkeMarchant, K ;
Eppell, SJ ;
Wilson, DL ;
Marchant, RE .
BLOOD, 1996, 88 (08) :2939-2950
[34]   Changes in plasma von Willebrand factor and ADAMTS13 levels associated with left atrial remodeling in atrial fibrillation [J].
Uemura, Takashi ;
Kaikita, Koichi ;
Yamabe, Hiroshige ;
Soejima, Kenji ;
Matsukawa, Masakazu ;
Fuchigami, Shunichiro ;
Tanaka, Yasuaki ;
Morihisa, Kenji ;
Enomoto, Koji ;
Sumida, Hitoshi ;
Sugiyama, Seigo ;
Ogawa, Hisao .
THROMBOSIS RESEARCH, 2009, 124 (01) :28-32
[35]   Relationship of Indices of Inflammation and Thrombogenesis to Arrhythmia Burden in Paroxysmal Atrial Fibrillation [J].
Watson, Timothy ;
Arya, Anita ;
Sulke, Neil ;
Lip, Gregory Y. H. .
CHEST, 2010, 137 (04) :869-876
[36]   Predicting left atrial thrombi in atrial fibrillation [J].
Wysokinski, Waldemar E. ;
Ammash, Naser ;
Sobande, Folakemi ;
Kalsi, Henna ;
Hodge, David ;
McBane, Robert D. .
AMERICAN HEART JOURNAL, 2010, 159 (04) :665-671
[37]   Transesophageal echocardiographic correlates of clinical risk of thromboembolism in nonvalvular atrial fibrillation [J].
Zabalgoitia, M ;
Halperin, JL ;
Pearce, LA ;
Blackshear, JL ;
Asinger, RW ;
Hart, RG .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1998, 31 (07) :1622-1626
[38]   Structure of von Willebrand factor-cleaving protease (ADAMTS13), a metalloprotease involved in thrombotic thrombocytopenic purpura [J].
Zheng, XL ;
Chung, D ;
Takayama, TK ;
Majerus, EM ;
Sadler, JE ;
Fujikawa, K .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (44) :41059-41063